TheAnalyst007 Bioshares is THE Biotech / Healthcare conference held annually and perfect audience for RSH. Good to see this activity happening and hopefully will get some momentum going amongst the brokers and retail investment community based on the strong operational fundamentals in the US. It is ridiculous for RSH to be trading at these levels based on where the company is at and the potential growth over the next 12 - 24 months, but difficult to overcome a SPP @ 3.4 cents and limited capital. Board / Management needs to really sell the true value of RSH in parallel with a few more significant deals coming on track.
RSH Price at posting:
3.5¢ Sentiment: Buy Disclosure: Held
